[ Pharmaceutical, medical and veterinary preparations, namely, polypeptides and proteins produced by genetic engineering, including fusion proteins, and body cells and cells of the immune system of mammals, all used for the treatment of graft rejections and/or viral infections and/or cancer by providing functional, antigen specific T cells for adoptive transfer ]